The main aspects of retinal vein occlusion etiopathogenisis in young adults. Part I. Neuroretinovasculitis (prothrombotic potential, clinical manifestations)

Cover Page

Cite item

Full Text

Abstract

This review is dedicated to the neuroretinovasculitis, which is the leading cause of retinal vein occlusion in young adults. Presumed etiological factors, possible pathogenic mechanisms, and clinical manifestation are analyzed. Advisability of multidisciplinary approach in management and individual approach in treatment of patients with neuroretinovasculitis with secondary retinal vein occlusion are justified.

About the authors

Svetlana N. Tultseva

Academician I.P. Pavlov First Saint Petersburg State Medical University

Author for correspondence.
Email: tultceva@yandex.ru

MD, PhD, Professor, Department of Ophthalmology

Russian Federation, Saint Petersburg

Alla B. Lisochkina

Academician I.P. Pavlov First Saint Petersburg State Medical University

Email: alan05@bk.ru

PhD, Assistant Professor, Department of Ophthalmology

Russian Federation, Saint Petersburg

Aleksandra I. Titarenko

Academician I.P. Pavlov First Saint Petersburg State Medical University

Email: Aleksandra-titarenko@yandex.ru

MD, Postgraduate Student, Department of Ophthalmology

Russian Federation, Saint Petersburg

Vadim A. Turgel

Academician I.P. Pavlov First Saint Petersburg State Medical University

Email: zanoza194@gmail.com

Student, Department of Ophthalmology

Russian Federation, Saint Petersburg

References

  1. Астахов Ю.С., Петрищев Н.Н., Варганова Т.С., Тульцева С.Н. Тромбофилии в патогенезе тромбоза ретинальных вен // Вестник офтальмологии. – 2008. – Т. 124. – № 3. – С. 56–58. [Asta khov YS, Petrishchev NN, Varganova TS, Tultseva SN. Thrombophilia in the pathogenesis of retinal vein thrombosis. Annals of ophthalmology. 2008;124(3):56-58. (In Russ.)]
  2. Нероев В.В., Танковский В.Э., Григорьев А.В., и др. Влияние однократного интравитреального введения бевацизумаба на остроту зрения и агрегацию тромбоцитов у больных с тромбозом вен сетчатки на фоне ангиита // Российский офтальмологический журнал. – 2013. – Т. 6. – № 3. – С. 67–70. [Neroev VV, Tankov skiy VE, Grigoryev AV, et al. The Changes of Visual Acuity and Platelet Aggregation in Patients with Retinal Vein Occlusion Accompanied by Angiitis after a Single Intravitreal Injection of Bevacizumab. Rossiiskii oftalmologicheskii zhurnal. 2013;6(3):67-70. (In Russ.)]
  3. Танковский В.Э. Тромбозы вен сетчатки. – М.: Воениздат, 2000. [Tankovskiy VE. Retinal vein thrombosis. Moscow: Voenizdat; 2000. (In Russ.)]
  4. Тульцева С.Н. Тромбофилия как фактор риска развития тромбозов центральной вены сетчатки у лиц молодого возраста // Офтальмологические ведомости. – 2008. – Т. 1. – № 1. – С. 46–51. [Tultseva SN. Thrombophilia as a Risk Factor of Central Retinal Vein Thrombosis Development among Young People. Ophthalmology Journal. 2008;1(1):46-51. (In Russ.)]
  5. Астахов Ю.С., Тульцева С.Н. Этиологические факторы развития тромбоза вен сетчатки у пациентов молодого возраста // Регионарное кровообращение и микроциркуляция. – 2004. – Т. 3. – № 4. – С. 39–42. [Astakhov YS, Tultseva SN. Etiological factors of retinal vein thrombosis development in young patients. Regionarnoe krovoobrashchenie i mikrotsirkuliatsiia. 2004;3(4):39-42. (In Russ.)]
  6. Тульцева С.Н. Значение гипергомоцистеинемии в патогенезе ишемического тромбоза вен сетчатки // Офтальмологические ведомости. – 2008. – Т. 1. – № 3. – С. 31–40. [Tultseva SN. The Significance of Hyperhomocysteinemia in the Pathogenesis of the Ischemic Thrombosis of Retinal Veins. Ophthalmology Journal. 2008;1(3):31-40. (In Russ.)]
  7. Abu El-Asrar AM, Al-Obeidan SA, Abdel Gader AGM. Retinal Periphlebitis Resembling Frosted Branch Angiitis with Nonperfused Central Retinal Vein Occlusion. Eur J Ophthalmol. 2018;13(9-10):807-812. doi: 10.1177/1120672103013009-1015.
  8. El-Asrar AM, Herbort CP, Tabbara KF. A clinical approach to the diagnosis of retinal vasculitis. Int Ophthalmol. 2010;30(2):149-73. doi: 10.1007/s10792-009-9301-3.
  9. Abu El-Asrar AM, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol. 2009;16(4):202-18. doi: 10.4103/0974-9233.58423.
  10. Abu El-Asrar AM, Herbort CP, Tabbara KF. Retinal vasculitis. Ocul Immunol Inflamm. 2005;13(6):415-433. doi: 10.1080/
  12. Al-Mezaine HS, Al-Muammar A, Kangave D, Abu El-Asrar AM. Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis. Int Ophthalmol. 2008;28(6):413-423. doi: 10.1007/s10792-007-9170-6.
  13. Appen RE, de Venecia G, Ferwerda J. Optic Disk Vasculitis. Am J Ophthalmol. 1980;90(3):352-359. doi: 10.1016/s0002-9394(14)74916-5.
  14. Biswas J, Ravi RK, Naryanasamy A, et al. Eales' disease – current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013;3(1):11. doi: 10.1186/1869-5760-3-11.
  15. Biswas J, Sharma T, Gopal L, et al. Eales Disease – An Update. Surv Ophthalmol. 2002;47(3):197-214. doi: 10.1016/s0039-6257(02)00288-6.
  16. Bodaghi B, Rozenberg F, Cassoux N, et al. Nonnecrotizing herpetic retinopathies masquerading as severe posterior uveitis. Ophthalmology. 2003;110(9):1737-1743. doi: 10.1016/s0161-6420(03)00580-3.
  17. Chang YC, Wu WC. Intravitreal triamcinolone acetonide for the management of papillophlebitis and associated macular edema. Int Ophthalmol. 2008;28(4):291-296. doi: 10.1007/s10792-007-9128-8.
  18. Cogan D. Retinal and Papillary Vasculitis. In: The Witham Mackenzie Centenary Symposium on Ocular Circulations and Disease. St. Louis: CV Mosby; 1969. P. 249-270.
  19. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335(8697):1078-1080.
  20. Deobhakta A, Chang LK. Inflammation in retinal vein occlusion. Int J Inflam. 2013;2013:438412. doi: 10.1155/2013/438412.
  21. Di Capua M, Coppola A, Albisinni R, et al. Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis. 2010;30(1):16-22. doi: 10.1007/s11239-009-0388-1.
  22. Duker JS, Sergott RC, Savino PJ, Bosley TM. Optic Neuritis with Secondary Retinal Venous Stasis. Ophthalmology. 1989;96(4):475-480. doi: 10.1016/s0161-6420(89)32871-5.
  23. Ehlers JP, Fekrat S. Retinal vein occlusion: beyond the acute event. Surv Ophthalmol. 2011;56(4):281-299. doi: 10.1016/j.survophthal.2010.11.006.
  24. Emmi G, Silvestri E, Squatrito D, et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thromb J. 2015;13:15. doi: 10.1186/s12959-015-0047-z.
  25. Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. 2009;23(5):225-229. doi: 10.1016/j.blre.2009.07.002.
  26. Figueiredo L, Rothwell R, Brandao A, Fonseca S. Central retinal vein occlusion in a patient with retinal vasculitis and Crohn's disease. Case Rep Ophthalmol Med. 2014;2014:967878. doi: 10.1155/
  27. /967878.
  28. Flammer J, Konieczka K. Retinal venous pressure: the role of endothelin. EPMA J. 2015;6:21. doi: 10.1186/s13167-015-0043-1.
  29. Fong AC, Schatz H, McDonald HR, et al. Central retinal vein occlusion in young adults (papillophlebitis). Retina. 1992;12(1):3-11.
  30. Fong ACO, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol. 1993;37(6):393-417. doi: 10.1016/0039-6257(93)90138-w.
  31. Garcia-Diaz M, Mira M, Nevado L, et al. Retinal vasculitis associated with Crohn's disease. Postgrad Med J. 1995;71(833):170-2. doi: 10.1136/pgmj.71.833.170.
  32. Gass JDM, Olson CL. Sarcoidosis With Optic Nerve and Retinal Involvement. Arch Ophthalmol. 1976;94(6):945-950. doi: 10.1001/archopht.1976.03910030475008.
  33. Ghadiali Q, Ghadiali LK, Yannuzzi LA. Bartonella Henselae Neuroretinitis Associated with Central Retinal Vein Occlusion, Choroidal Ischemia, and Ischemic Optic Neuropathy. Retin Cases Brief Rep. 2017. doi: 10.1097/ICB.0000000000000612.
  34. Glueck CJ, Ping W, Hutchins R, et al. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions. Clin Appl Thromb Hemost. 2008;14(3):286-294. doi: 10.1177/1076029607304726.
  35. Gray AV, Michels KS, Lauer AK, Samples JR. Bartonella henselae infection associated with neuroretinitis, central retinal artery and vein occlusion, neovascular glaucoma, and severe vision loss. Am J Ophthalmol. 2004;137(1):187-189. doi: 10.1016/s0002-9394(03)00784-0.
  36. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371-422.
  37. Greifner G, Neri P, Amer R. Frosted branch angiitis complicated by retinal vein occlusion: clinical course and long-term visual outcome. Graefes Arch Clin Exp Ophthalmol. 2016;254(3):541-544. doi: 10.1007/s00417-015-3255-0.
  38. Grosso A, Calzada JI, Randolph J, Sigler E. Papillophlebitis: a closer look. Retina Today. 2017;12(5):32-38.
  39. Guex-Crosier Y, Pittet N, Herbort CP. Sensitivity of Laser Flare Photometry to Monitor Inflammation in Uveitis of the Posterior Segment. Ophthalmology. 1995;102(4):613-621. doi: 10.1016/s0161-6420(95)30976-1.
  40. Harold Lee HB, Pulido JS, McCannel CA, Buettner H. Role of inflammation in retinal vein occlusion. Can J Ophthalmol. 2007;42(1):131-133. doi: 10.3129/can.j.ophthalmol.06-101.
  41. Hart D, Miller S. Benign Retinal Vasculitis. Br J Ophthalmol. 1971;55:721-733.
  42. Hayreh SS. Optic disc vasculitis. Br J Ophthalmol. 1972;56(9):
  43. -670. doi: 10.1136/bjo.56.9.652.
  44. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001;131(1):61-77. doi: 10.1016/s0002-9394(00)00709-1.
  45. Hoyt W. A Syndrome of Unilateral Disc Swelling, Enlarged Blind Spot and Photopsia. In: Proceedings of the 2nd Congress of the International Society of Neuro-Ophthalmology; 1978 May 1; Airlie House.
  46. Hughes EH, Dick AD. The pathology and pathogenesis of retinal vasculitis. Neuropathol Appl Neurobiol. 2003;29(4):325-340. doi: 10.1046/j.1365-2990.2003.00499.x.
  47. Kuo JZ, Lai CC, Ong FS, et al. Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality. Retina. 2010;30(3):479-484. doi: 10.1097/IAE.0b013e3181b9b3a0.
  48. Kalogeropoulos CD, Bassukas ID, Moschos MM, Tabbara KF. Eye and Periocular Skin Involvement in Herpes Zoster Infection. Med Hypothesis Discov Innov Ophthalmol. 2015;4(4):142-156.
  49. Karia N. Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol. 2010;4:809-816.
  50. Karska-Basta I, Kubicka-Trzaska A, Romanowska-Dixon B, Undas A. Thrombophilia – a risk factor of retinal vein occlusion? Klin Oczna. 2013;115(1):29-33.
  51. Albert K, Masset M, Bonnet S, et al. Long-term follow-up of herpetic non-necrotizing retinopathy with occlusive retinal vasculitis and neovascularization. J Ophthalmic Inflamm Infect. 2015;5:6. doi: 10.1186/s12348-015-0038-z.
  52. Kim JY, Lee JH, Lee CS, Lee SC. Varicella zoster virus-associated Chorioretinitis: a case report. BMC Ophthalmol. 2018;18(1):28. doi: 10.1186/s12886-018-0696-3.
  53. Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. 2014;2014:724780. doi: 10.1155/2014/724780.
  54. Kumawat B, Tripathy K, Venkatesh P, et al. Central Retinal Vein Occlusion-like Appearance: A Precursor Stage in Evolution of Frosted Branch Angiitis. J Ophthalmic Vis Res. 2017;12(4):
  55. -442. doi: 10.4103/jovr.jovr_84_15.
  56. López JA, Chen J. Pathophysiology of venous thrombosis. Thromb Res. 2009;123:S30-S34. doi: 10.1016/s0049-3848(09)70140-9.
  57. Lyle TK, Wybar K. Retinal Vasculitis. Br J Ophthalmol. 1961;45(12):778-788. doi: 10.1136/bjo.45.12.778.
  58. Madhavan HN, Therese KL, Gunisha P, et al. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales' disease. Invest Ophthalmol Vis Sci. 2000;41(3):822-825.
  59. Maugeri N, Baldini M, Ramirez GA, et al. Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases. Thromb Res. 2012;129(3):267-273. doi: 10.1016/j.thromres.2011.12.001.
  60. McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry. 1992;55(9):747-752.
  61. Stanford MR, Verity DH. Diagnostic and therapeutic approach to patients with retinal vasculitis. Int Ophthalmol Clin. 2000;40(2):69-83.
  62. Miserocchi E, Modorati G, Azzolini C, et al. Herpes Simplex Virus Type 2 Acute Retinal Necrosis in an Immunocompetent Patient. Eur J Ophthalmol. 2018;13(1):99-102. doi: 10.1177/112067210301300118.
  63. Nakao K, Ohba N. Human T-Cell Lymphotropic Virus Type 1-Associated Retinal Vasculitis in Children. Retina. 2003;23(2):197-201. doi: 10.1097/00006982-200304000-00010.
  64. Nguyen ML, Blaho JA. Apoptosis During Herpes Simplex Virus Infection. Adv Virus Res. 2006;69:67-97. doi: 10.1016/s0065-3527(06)69002-7.
  65. Odeberg J, Wolmer N, Falci S, et al. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J Virol. 2006;80(18):8929-8939. doi: 10.1128/JVI.00676-06.
  66. Okada AA. Drug therapy in Behçet's disease. Ocul Immunol Inflamm. 2009;8(2):85-91. doi: 10.1076/0927-3948(200006)821-0ft085.
  67. Paovic J, Paovic P, Sredovic V. Behcet's disease: systemic and ocular manifestations. Biomed Res Int. 2013;2013:247345. doi: 10.1155/2013/247345.
  68. Papadia M, Misteli M, Jeannin B, Herbort CP. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications. Int Ophthalmol. 2014;34(6):1193-1201. doi: 10.1007/s10792-014-0002-1.
  69. Patte M, Rouher FN, Vernay D, et al. Proliferative retinal vasculitis and multiple sclerosis: a case report. J Fr Ophtalmol. 2003;26(4):381-385.
  70. Quillen DA, Stathopoulos NA, Blankenship GW, Ferriss JA. Lupus Associated Frosted Branch Periphlebitis and Exudative Maculopathy. Retina. 1997;17(5):449-451. doi: 10.1097/00006982-199709000-00016.
  71. Rehak M, Rehak J, Muller M, et al. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis. Thromb Haemost. 2008;99(5):925-929. doi: 10.1160/TH07-11-0658.
  72. Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost. 2010;8(9):1886-1894. doi: 10.1111/j.1538-7836.2010.03909.x.
  73. Rochat C, Polla BS, Herbort CP. Immunological profiles in patients with acute retinal necrosis. Graefes Arch Clin Exp Ophthalmol. 1996;234(9):547-552. doi: 10.1007/bf00448798.
  74. Rosen PH, Spalton DJ, Graham EM. Intraocular tuberculosis. Eye (Lond). 1990;4(Pt 3):486-492. doi: 10.1038/eye.1990.63.
  75. Sharief L, Lightman S, Blum-Hareuveni T, et al. Clinical Outcome of Retinal Vasculitis and Predictors for Prognosis of Ischemic Retinal Vasculitis. Am J Ophthalmol. 2017;177:206-212. doi: 10.1016/j.ajo.2017.02.028.
  76. Singh R, Toor P, Parchand S, et al. Quantitative polymerase chain reaction for Mycobacterium tuberculosis in so-called Eales' disease. Ocul Immunol Inflamm. 2012;20(3):153-157. doi: 10.3109/09273948.2012.658134.
  77. Sofi F, Marcucci R, Bolli P, et al. Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis. 2008;198(1):223-227. doi: 10.1016/j.atherosclerosis.2007.09.009.
  78. Springer J, Villa-Forte A. Thrombosis in vasculitis. Curr Opin Rheumatol. 2013;25(1):19-25. doi: 10.1097/BOR.0b013e32835ad3ca.
  79. Sinawat S, Bunyavee C, Ratanapakorn T, et al. Systemic abnormalities associated with retinal vein occlusion in young patients. Clin Ophthalmol. 2017;11:441-447. doi: 10.2147/OPTH.S128341.
  80. Sykes SO, Horton JC. Steroid-Responsive Retinal Vasculitis with a Frosted Branch Appearance in Crohns Disease. Retina. 1997;17(5):451-454. doi: 10.1097/00006982-199709000-00017.
  81. Tajunisah I, Reddy SC, Tan LH. Acute retinal necrosis by cytomegalovirus in an immunocompetent adult: case report and review of the literature. Int Ophthalmol. 2009;29(2):85-90. doi: 10.1007/s10792-007-9171-5.
  82. Talat L, Lightman S, Tomkins-Netzer O. Ischemic retinal vasculitis and its management. J Ophthalmol. 2014;2014:197675. doi: 10.1155/2014/197675.
  83. Taylor SR, Singh J, Menezo V, et al. Behcet disease: visual prognosis and factors influencing the development of visual loss. Am J Ophthalmol. 2011;152(6):1059-1066. doi: 10.1016/j.ajo.2011.05.032.
  84. Trese MGJ, Yonekawa Y, Thomas BJ, Randhawa S. Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis. Am J Ophthalmol Case Rep. 2016;2:26-29. doi: 10.1016/j.ajoc.2016.04.007.
  85. Tugal-Tutkun I, Yalçındağ FN, Herbort CP. Laser flare photometry and its use in uveitis. Expert Rev Ophthalmol. 2014;7(5):449-457. doi: 10.1586/eop.12.47.
  86. Turner SJ, Dharmasena A, Deane J. Bilateral rubeosis iridis and rubeotic glaucoma due to peripheral occlusive vasculitis associated with multiple sclerosis. Ocul Immunol Inflamm. 2011;19(5):
  87. -375. doi: 10.3109/09273948.2011.602500.
  88. Verity DH. Behcet's disease: from Hippocrates to the third millennium. Br J Ophthalmol. 2003;87(9):1175-1183. doi: 10.1136/bjo.87.9.1175.
  89. Vrioni G, Kalogeropoulos C, Gartzonika C, et al. Usefulness of Herpes Consensus PCR methodology to routine diagnostic testing for herpesviruses infections in clinical specimens. Virol J. 2007;4:59. doi: 10.1186/1743-422X-4-59.
  90. Wensing B, de Groot-Mijnes JD, Rothova A. Necrotizing and nonnecrotizing variants of herpetic uveitis with posterior segment involvement. Arch Ophthalmol. 2011;129(4):403-408. doi: 10.1001/archophthalmol.2010.313.
  91. Yang P, Fang W, Huang X, et al. Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet's disease. Int Ophthalmol. 2010;30(5):485-9. doi: 10.1007/s10792-008-9229-z.
  92. Yoser SL, Forster DJ, Rao NA. Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol. 1993;37(5):313-352. doi: 10.1016/0039-6257(93)90064-e.
  93. Yoshizawa C, Saito W, Kase M, Ishida S. Clinical Features of Central Retinal Vein Occlusion With Inflammatory Etiology. Asia Pac J Ophthalmol (Phila). 2012;1(5):270-276. doi: 10.1097/APO.0b013e318266de04.
  94. Ysasaga JE. Frosted Branch Angiitis With Ocular Toxoplasmosis. Arch Ophthalmol. 1999;117(9):1260. doi: 10.1001/archopht.117.9.1260.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Pathogenesis of retinal vein occlusion against the background of neuroretinovasculitis

Download (354KB)
Indexing metadata

Copyright (c) 2018 Tultseva S.N., Lisochkina A.B., Titarenko A.I., Turgel V.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies